Tokai names John McBride COO
This article was originally published in Scrip
Tokai Pharmaceuticals, a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, has named John McBride chief operating officer. Prior to joining Cambridge, Massachusetts-based Tokai Mr McBride founded and served as president of Alliance Life Science Advisors, a consulting firm focused on assisting life science companies with strategic planning, business development and financing projects.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.